Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6550-6558

  Park, Keun Hyung ^a   Lee, Tae Hoon ^a   Kim, Chan Woo ^b   Kim, Jiyoung ^a  

^a Kyung Hee University   (South Korea)

^b Emory University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL15 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE 2; LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL HYPOXIA; CELL STIMULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REOXYGENATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANOXIA; BLOTTING, WESTERN; CELL ADHESION; CELLS, CULTURED; CHEMOKINES, CC; CHROMATIN IMMUNOPRECIPITATION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; JANUS KINASE 2; MACROPHAGE INFLAMMATORY PROTEINS; MONOCYTES; MUTAGENESIS, SITE-DIRECTED; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION; UP-REGULATION;

EID: 84879082926     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202284     Document Type: Article

References (42)

1. Zweier, J. L., P. Kuppusamy, S. Thompson-Gorman, D. Klunk, and G. A. Lutty. 1994. Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Am. J. Physiol. 266: C700-C708. (Pubitemid 24115743)
2. Shreeniwas, R., S. Koga, M. Karakurum, D. Pinsky, E. Kaiser, J. Brett, B. A. Wolitzky, C. Norton, J. Plocinski, W. Benjamin, et al. 1992. Hypoxia-mediated induction of endothelial cell interleukin-1a. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J. Clin. Invest. 90: 2333-2339. (Pubitemid 23010050)
3. Kupatt, C., C. Weber, D. A. Wolf, B. F. Becker, T. W. Smith, and R. A. Kelly. 1997. Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: role of NFkB. J. Mol. Cell. Cardiol. 29: 2599-2609. (Pubitemid 27466483)
4. Fan, H., B. Sun, Q. Gu, A. Lafond-Walker, S. Cao, and L. C. Becker. 2002. Oxygen radicals trigger activation of NF-κB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am. J. Physiol. Heart Circ. Physiol. 282: H1778-H1786. (Pubitemid 34654847)
5. Rao, R. M., L. Yang, G. Garcia-Cardena, and F. W. Luscinskas. 2007. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ. Res. 101: 234-247. (Pubitemid 47344073)
6. Williams, M. R., V. Azcutia, G. Newton, P. Alcaide, and F. W. Luscinskas. 2011. Emerging mechanisms of neutrophil recruitment across endothelium. Trends Immunol. 32: 461-469.
7. Roebuck, K. A., and A. Finnegan. 1999. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol. 66: 876-888. (Pubitemid 30010511)
8. Meager, A. 1999. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 10: 27-39. (Pubitemid 29230850)
9. Jahnke, A., and J. P. Johnson. 1994. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-α and IFN-γ is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 a (p91) that can be activated by both IFN-γ and IFN-α. FEBS Lett. 354: 220-226. (Pubitemid 24335512)
10. Amin, M. A., C. S. Haas, K. Zhu, P. J. Mansfield, M. J. Kim, N. P. Lackowski, and A. E. Koch. 2006. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFκB. Blood 107: 2252-2261. (Pubitemid 43345542)
11. Minhajuddin, M., K. M. Bijli, F. Fazal, A. Sassano, K. I. Nakayama, N. Hay, L. C. Platanias, and A. Rahman. 2009. Protein kinase C-δ and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-κB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. J. Biol. Chem. 284: 4052-4061.
12. Caldenhoven, E., P. Coffer, J. Yuan, A. Van de Stolpe, F. Horn, W. Kruijer, and P. T. Van der Saag. 1994. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-γ involves binding of distinct factors to a palindromic response element. J. Biol. Chem. 269: 21146-21154. (Pubitemid 24266488)
13. Simon, A. R., U. Rai, B. L. Fanburg, and B. H. Cochran. 1998. Activation of the JAK-STAT pathway by reactive oxygen species. Am. J. Physiol. 275: C1640-C1652.
14. Yuan, J., U. M. Wegenka, C. Lütticken, J. Buschmann, T. Decker, C. Schindler, P. C. Heinrich, and F. Horn. 1994. The signalling pathways of interleukin-6 and γ interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol. Cell. Biol. 14: 1657-1668. (Pubitemid 24074561)
15. Walter, M. J., D. C. Look, R. M. Tidwell, W. T. Roswit, and M. J. Holtzman. 1997. Targeted inhibition of interferon-gamma-dependent intercellular adhesion molecule-1 (ICAM-1) expression using dominant-negative Stat1. J. Biol. Chem. 272: 28582-28589. (Pubitemid 27517811)
16. Zernecke, A., E. Shagdarsuren, and C. Weber. 2008. Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 28: 1897-1908.
17. Lee, W. H., S. H. Kim, E. M. Jeong, Y. H. Choi, D. I. Kim, B. B. Lee, Y. S. Cho, B. S. Kwon, and J. E. Park. 2002. A novel chemokine, leukotactin-1, induces chemotaxis, pro-atherogenic cytokines, and tissue factor expression in atherosclerosis. Atherosclerosis 161: 255-260.
18. Yu, R., C. S. Kim, T. Kawada, T. W. Kwon, T. H. Lim, Y. W. Kim, and B. S. Kwon. 2004. Involvement of leukotactin-1, a novel CC chemokine, in human atherosclerosis. Atherosclerosis 174: 35-42. (Pubitemid 38595437)
19. Pawlak, K., D. Pawlak, S. Brzosko, and M. Mysliwiec. 2006. Carotid atherosclerosis is associated with enhanced β-chemokine levels in patients on continuous ambulatory peritoneal dialysis. Atherosclerosis 186: 146-151.
20. Zhang, S., B. S. Youn, J. L. Gao, P. M. Murphy, and B. S. Kwon. 1999. Differential effects of leukotactin-1 and macrophage inflammatory protein-1α on neutrophils mediated by CCR1. J. Immunol. 162: 4938-4942. (Pubitemid 29314900)
21. Hwang, J., C. W. Kim, K. N. Son, K. Y. Han, K. H. Lee, H. K. Kleinman, J. Ko, D. S. Na, B. S. Kwon, Y. S. Gho, and J. Kim. 2004. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett. 570: 47-51. (Pubitemid 38900954)
22. Youn, B. S., S. M. Zhang, E. K. Lee, D. H. Park, H. E. Broxmeyer, P. M. Murphy, M. Locati, J. E. Pease, K. K. Kim, K. Antol, and B. S. Kwon. 1997. Molecular cloning of leukotactin-1: a novel human β-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J. Immunol. 159: 5201-5205. (Pubitemid 127470044)
23. O'Shea, J. J., and R. Plenge. 2012. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36: 542-550.
24. Pfeffer, L. M., J. E. Mullersman, S. R. Pfeffer, A. Murti, W. Shi, and C. H. Yang. 1997. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276: 1418-1420. (Pubitemid 27235410)
25. Kim, C. W., T. H. Lee, K. H. Park, S. Y. Choi, and J. Kim. 2012. Human lactoferrin suppresses TNF-α-induced intercellular adhesion molecule-1 expression via competition with NF-κB in endothelial cells. FEBS Lett. 586: 229-234.
26. Lee, H. Y., S. Y. Lee, S. D. Kim, J. W. Shim, H. J. Kim, Y. S. Jung, J. Y. Kwon, S. H. Baek, J. Chung, and Y. S. Bae. 2011. Sphingosylphosphorylcholine stimulates CCL2 production from human umbilical vein endothelial cells. J. Immunol. 186: 4347-4353.
27. Sorescu, G. P., M. Sykes, D. Weiss, M. O. Platt, A. Saha, J. Hwang, N. Boyd, Y. C. Boo, J. D. Vega, W. R. Taylor, and H. Jo. 2003. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J. Biol. Chem. 278: 31128-31135. (Pubitemid 36994628)
28. Björnheden, T., M. Levin, M. Evaldsson, and O. Wiklund. 1999. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler. Thromb. Vasc. Biol. 19: 870-876. (Pubitemid 29177331)
29. Crowther, M., N. J. Brown, E. T. Bishop, and C. E. Lewis. 2001. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukoc. Biol. 70: 478-490. (Pubitemid 32954759)
30. Semenza, G. L. 2001. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7: 345-350. (Pubitemid 32735019)
31. Distler, J. H., R. H. Wenger, M. Gassmann, M. Kurowska, A. Hirth, S. Gay, and O. Distler. 2004. Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 50: 10-23. (Pubitemid 38084283)
32. Mattagajasingh, S. N., X. P. Yang, K. Irani, I. Mattagajasingh, and L. C. Becker. 2012. Activation of Stat3 in endothelial cells following hypoxia-reoxygenation is mediated by Rac1 and protein kinase C. Biochim. Biophys. Acta 1823: 997-1006.
33. Shin, Y. H., J. J. Shim, M. W. Hur, C. J. Kang, and J. Kim. 2004. Involvement of two NF-κB binding sites in PMA-induced expression of the human leukotactin-1/CCL15 gene in U937 monocytoid cells. Mol. Cells 17: 316-321. (Pubitemid 39137083)
34. Libby, P. 2002. Inflammation in atherosclerosis. Nature 420: 868-874. (Pubitemid 36019640)
35. Krohn, R., U. Raffetseder, I. Bot, A. Zernecke, E. Shagdarsuren, E. A. Liehn, P. J. van Santbrink, P. J. Nelson, E. A. Biessen, P. R. Mertens, and C. Weber. 2007. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 116: 1812-1820. (Pubitemid 350287106)
36. Weber, C., K. S. Weber, C. Klier, S. Gu, R. Wank, R. Horuk, and P. J. Nelson. 2001. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and TH1-like/CD45RO+ T cells. Blood 97: 1144-1146. (Pubitemid 32154307)
37. Braunersreuther, V., A. Zernecke, C. Arnaud, E. A. Liehn, S. Steffens, E. Shagdarsuren, K. Bidzhekov, F. Burger, G. Pelli, B. Luckow, et al. 2007. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27: 373-379. (Pubitemid 46143054)
38. Zernecke, A., E. A. Liehn, J. L. Gao, W. A. Kuziel, P. M. Murphy, and C. Weber. 2006. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood 107: 4240-4243. (Pubitemid 43801346)
39. Wong, M., S. Uddin, B. Majchrzak, T. Huynh, A. E. Proudfoot, L. C. Platanias, and E. N. Fish. 2001. Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells. J. Biol. Chem. 276: 11427-11431. (Pubitemid 38089337)
40. Mueller, A., and P. G. Strange. 2004. CCL3, acting via the chemokine receptor CCR5, leads to independent activation of Janus kinase 2 (JAK2) and Gi proteins. FEBS Lett. 570: 126-132. (Pubitemid 38900969)
41. Stahl, N., T. J. Farruggella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr., and G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349-1353.
42. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.